Opti Capital Management »

Biomarin Pharmaceutical shares owned by Opti Capital Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Opti Capital Management from 13F filings

Historical chart of Opti Capital Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Opti Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Opti Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $31B 32M 951.25
2025-03-31 $13B 14M 948.50
2024-12-31 $13B 14M 932.50

More positions owned by Opti Capital Management

Block Note 0.250%11/0 (Principal)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Interdigital Note 3.500% 6/0 (Principal)
Halozyme Therapeutics Note 0.250% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Sea Note 0.250% 9/1 (Principal)
Enphase Energy Note 3/0 (Principal)
Snap Note 0.125% 3/0 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Fastly Note 3/1 (Principal)
Transmedics Group Note 1.500% 6/0 (Principal)
Bentley Sys Note 0.375% 7/0 (Principal)
Western Digital Corp Note 3.000%11/1 (Principal)

View all positions for Opti Capital Management

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Ing Investment Management
BlackRock
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Wellesley Investment Advisors
Millennium Management
Lazard Asset Management
Oaktree Capital Management
Victory Capital Management
Bnp Paribas Arbitrage, Snc
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Biomarin Pharmaceutical